Canada Pension Plan Investment Board
SCMP

Canada Pension Plan Investment Board’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Canada Pension Plan Investment Board’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,200
Closed -$9K – 1341
2014
Q1 		$9K Buy
+1,200
New +$10.3K ﹤0.01% 1279

Other funds holding SCMP

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Canada Pension Plan Investment Board's SCMP Position: Q2 2014 in Review

Canada Pension Plan Investment Board sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2014, closing a stake of 1,200 shares — an estimated $9K sold.

Canada Pension Plan Investment Board first reported a position in SCMP in Q1 2014 and held it in 1 quarter. The position peaked at $9K in Q1 2014. 71 funds tracked by Wall St. Rank hold SCMP as of Q2 2014.

  • Canada Pension Plan Investment Board reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 1,200 Sucampo Pharmaceuticals, Inc. shares in Q2 2014, an estimated $9K.
  • Canada Pension Plan Investment Board first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2014 and held it in 1 quarter.
  • Canada Pension Plan Investment Board's Sucampo Pharmaceuticals, Inc. position peaked at $9K in Q1 2014.
  • 71 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2014.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2014, filed 13 Aug 2014.